Anastrozole

Product NDC: 68001-155
11-digit product format: 680010155
Labeler code: 68001
Product ID: 68001-155_2dc9d4ae-4fbc-df45-e063-6394a90a09a0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Anastrozole
Dosage form: TABLET, COATED
Route: ORAL
Labeler: BluePoint Laboratories
Application: ANDA078921
Marketing category: ANDA
Marketing start: 2014-01-01
Substance: ANASTROZOLE
Active strength: 1 mg/1
Pharmacologic classes: Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A078921-001	ANASTROZOLE	ANASTROZOLE	1MG	TABLET / ORAL	AB		2010-06-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A078921-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A078921-001	ANASTROZOLE	1MG	TABLET / ORAL	AB	2010-06-28	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A078921-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078921-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078921-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078921-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078921-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078921-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078921-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078921-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078921-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078921-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078921-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078921-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078921-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078921-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078921-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078921-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078921-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078921-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A078921-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A078921-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A078921-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A078921-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A078921-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A078921-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A078921-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A078921-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A078921-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A078921-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A078921-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A078921-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A078921-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A078921-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A078921-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A078921-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A078921-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A078921-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A078921-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A078921-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A078921-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A078921-001	AB	1	`e64feba35796…`

Additional Listing Data#

Finished product: Yes
Brand name base: Anastrozole
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ANASTROZOLE	1 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2Z07MYW1AZ	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
199224	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3cd04ed6-7c5a-4c4a-9955-ee40839dfea0	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9495fd23-86bb-d8f7-ae78-6dfe2f4dae2d	Product name	3	20210204

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68001-155-04	Anastrozole	30 in 1 BOTTLE	TABLET, COATED	30		10
68001-155-08	Anastrozole	1000 in 1 BOTTLE	TABLET, COATED	1000		10

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ANASTROZOLE	ACTIVE INGREDIENT	2Z07MYW1AZ	ANASTROZOLE TABLET, COATED [BLUEPOINT LABORATORIES]	3
ANASTROZOLE	ACTIVE MOIETY	2Z07MYW1AZ	ANASTROZOLE TABLET, COATED [BLUEPOINT LABORATORIES]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ANASTROZOLE TABLET, COATED [BLUEPOINT LABORATORIES]	3
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	ANASTROZOLE TABLET, COATED [BLUEPOINT LABORATORIES]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ANASTROZOLE TABLET, COATED [BLUEPOINT LABORATORIES]	3
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ANASTROZOLE TABLET, COATED [BLUEPOINT LABORATORIES]	3
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	ANASTROZOLE TABLET, COATED [BLUEPOINT LABORATORIES]	3
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	ANASTROZOLE TABLET, COATED [BLUEPOINT LABORATORIES]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ANASTROZOLE TABLET, COATED [BLUEPOINT LABORATORIES]	3
ANASTROZOLE	ACTIVE INGREDIENT	2Z07MYW1AZ	ANASTROZOLE TABLET, COATED [AMERICAN HEALTH PACKAGING]	1
ANASTROZOLE	ACTIVE MOIETY	2Z07MYW1AZ	ANASTROZOLE TABLET, COATED [AMERICAN HEALTH PACKAGING]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ANASTROZOLE TABLET, COATED [AMERICAN HEALTH PACKAGING]	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	ANASTROZOLE TABLET, COATED [AMERICAN HEALTH PACKAGING]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ANASTROZOLE TABLET, COATED [AMERICAN HEALTH PACKAGING]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ANASTROZOLE TABLET, COATED [AMERICAN HEALTH PACKAGING]	1
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	ANASTROZOLE TABLET, COATED [AMERICAN HEALTH PACKAGING]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	ANASTROZOLE TABLET, COATED [AMERICAN HEALTH PACKAGING]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ANASTROZOLE TABLET, COATED [AMERICAN HEALTH PACKAGING]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68001-155	ANASTROZOLE TABLET, COATED [BLUEPOINT LABORATORIES]	10	Current NDC, Legacy NDC, 2 package rows	20250212_3cd04ed6-7c5a-4c4a-9955-ee40839dfea0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Anastrozole	ANASTROZOLE	Bryant Ranch Prepack	f5b53383-0366-4ae2-9aa4-88b56c0bbd07	2026-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078921 application number: ANDA078921
Anastrozole	ANASTROZOLE	American Health Packaging	dface914-5135-4136-82f4-75429b496a35	2025-08-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078921 application number: ANDA078921
Anastrozole	ANASTROZOLE	PD-Rx Pharmaceuticals, Inc.	b023a9f2-1a99-4b40-a953-edac7e3a79bf	2025-02-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078921 application number: ANDA078921
Anastrozole	ANASTROZOLE	BluePoint Laboratories	3cd04ed6-7c5a-4c4a-9955-ee40839dfea0	2025-02-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078921 application number: ANDA078921 ndc (product): 68001-155
Anastrozole	ANASTROZOLE	Zydus Pharmaceuticals USA Inc.	ca16f8de-d9a5-4c6c-957b-ae28497b67ac	2025-01-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078921 application number: ANDA078921
Anastrozole	ANASTROZOLE	Zydus Lifesciences Limited	965c4cb1-f6b8-47ac-bf13-c36639aa908f	2024-11-25		Exact identifier application applno (ANDA): 078921 application number: ANDA078921

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
2Z07MYW1AZ	ANASTROZOLE	120511-73-1	ANASTROZOLE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
199224	anastrozole 1 MG Oral Tablet	PSN	3cd04ed6-7c5a-4c4a-9955-ee40839dfea0	10
199224	anastrozole 1 MG Oral Tablet	SCD	3cd04ed6-7c5a-4c4a-9955-ee40839dfea0	10
199224	anastrozole 1 MG Oral Tablet	PSN	dface914-5135-4136-82f4-75429b496a35	8
199224	anastrozole 1 MG Oral Tablet	SCD	dface914-5135-4136-82f4-75429b496a35	8

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
68001-155-04	68001015504	30 TABLET, COATED in 1 BOTTLE (68001-155-04)	2014-01-01	0000-00-00	No	No	Current
68001-155-08	68001015508	1000 TABLET, COATED in 1 BOTTLE (68001-155-08)	2014-01-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Anastrozole	American Health Packaging	2025-08-29	HUMAN PRESCRIPTION DRUG LABEL	8
Anastrozole	BluePoint Laboratories \| Zydus Pharmaceuticals (USA) Inc. \| Zydus Lifesciences Limited	2025-02-10	HUMAN PRESCRIPTION DRUG LABEL	10